MWNA
EPZM

Marshall Wace North America’s Epizyme, Inc EPZM Stock Holding History

Marshall Wace North America’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,358
Closed -$123K – 1687
2020
Q3 		$123K Sell
10,358
-58,570
-85% -$785K ﹤0.01% 1154
2020
Q2 		$1.11M Buy
68,928
+29,016
+73% +$506K 0.01% 732
2020
Q1 		$619K Buy
+39,912
New +$857K ﹤0.01% 713
2019
Q2 		– Sell
-18,942
Closed -$235K – 1767
2019
Q1 		$235K Buy
+18,942
New +$212K ﹤0.01% 950
2018
Q3 		– Sell
-138,239
Closed -$1.87M – 1502
2018
Q2 		$1.87M Buy
+138,239
New +$2.15M 0.01% 780

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return